跳到正文
MarketHOT
English
摘要
SEC · EDGAR 财务披露·· 12 天前AI 评分11

Nanobiotix S.A. 提交 6-K,附 11 月 9 日新闻稿

6-K - Nanobiotix S.A. (0001760854) (Filer)

AI 导读

Nanobiotix S.A. 于 11 月 9 日发布新闻稿,并提交 6-K 报告,将该新闻稿作为附件 99.1 纳入文件。公司勾选 Form 20-F 作为年度报告提交表格。

正文

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2026

Commission File Number: 001-39777

Nanobiotix S.A.
(Translation of registrant's name into English)

60 Rue de Wattignies 75012 Paris, France
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ]      Form 40-F [   ]


On November 9, 2026, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

(c) Exhibit 99.1. Press release dated November 9, 2026


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

      Nanobiotix S.A.    
  (Registrant)
   
  
Date: November 9, 2026     /s/ Brandon Owens    
  Brandon Owens
  Vice President, Strategic Marketing and Corporate Communications
  

来源:SEC EDGAR · 本站存档